1. Home
  2. VERU vs SUNS Comparison

VERU vs SUNS Comparison

Compare VERU & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • SUNS
  • Stock Information
  • Founded
  • VERU 1971
  • SUNS 2023
  • Country
  • VERU United States
  • SUNS United States
  • Employees
  • VERU N/A
  • SUNS N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • SUNS Real Estate Investment Trusts
  • Sector
  • VERU Health Care
  • SUNS Real Estate
  • Exchange
  • VERU Nasdaq
  • SUNS Nasdaq
  • Market Cap
  • VERU 107.2M
  • SUNS 104.3M
  • IPO Year
  • VERU 1990
  • SUNS N/A
  • Fundamental
  • Price
  • VERU $0.58
  • SUNS $14.81
  • Analyst Decision
  • VERU Strong Buy
  • SUNS Buy
  • Analyst Count
  • VERU 4
  • SUNS 1
  • Target Price
  • VERU $4.00
  • SUNS $17.50
  • AVG Volume (30 Days)
  • VERU 996.7K
  • SUNS 36.6K
  • Earning Date
  • VERU 12-06-2024
  • SUNS 11-07-2024
  • Dividend Yield
  • VERU N/A
  • SUNS 4.25%
  • EPS Growth
  • VERU N/A
  • SUNS N/A
  • EPS
  • VERU N/A
  • SUNS 0.03
  • Revenue
  • VERU $14,091,909.00
  • SUNS $734,226.00
  • Revenue This Year
  • VERU N/A
  • SUNS N/A
  • Revenue Next Year
  • VERU N/A
  • SUNS N/A
  • P/E Ratio
  • VERU N/A
  • SUNS $145.72
  • Revenue Growth
  • VERU N/A
  • SUNS N/A
  • 52 Week Low
  • VERU $0.36
  • SUNS $8.11
  • 52 Week High
  • VERU $1.92
  • SUNS $15.74
  • Technical
  • Relative Strength Index (RSI)
  • VERU 24.06
  • SUNS N/A
  • Support Level
  • VERU $0.72
  • SUNS N/A
  • Resistance Level
  • VERU $0.83
  • SUNS N/A
  • Average True Range (ATR)
  • VERU 0.06
  • SUNS 0.00
  • MACD
  • VERU -0.02
  • SUNS 0.00
  • Stochastic Oscillator
  • VERU 1.38
  • SUNS 0.00

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

Share on Social Networks: